Author

Congcong Lyu

The University of Texas at Austin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

5· 1 shared Bradley A. WebbiD· 1 shared Crystal N. WilsoniD· 1 shared Eric M. LynchiD· 1 shared Gibae KimiD· 1 shared Hayden T. Hess· 1 shared Hsin‐Ru Chan· 1 shared Justin M. KollmaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Covalent PFKL Activator Suppresses Tumor Growth

Xiaoding Jiang, Eric M. Lynch, Congcong Lyu, Crystal N. Wilson, Lauren E. Salay, Hayden T. Hess, Scott N. Lyons, Shuangyu Luo, Gibae Kim, Hsin‐Ru Chan, 5, Lauren G. Zacharias, Thomas P. Mathews, Yi‐Chih Lin, Bradley A. Webb, , Ku‐Lung Hsu

This paper develops a covalent PFKL activator that disrupts cancer cell metabolism and delivers a cytotoxic payload, showing efficacy in vitro and in vivo.

Nature Chemical Biology · Aug 5, 2026Peer-reviewedBiochemistry